{
  "schemaVersion" : 2,
  "registerId" : "F2012L00009",
  "instrumentNumber" : "5/2012",
  "citation" : "Statement of Principles concerning psoriatic arthropathy No. 5 of 2012",
  "conditionName" : "psoriatic arthropathy",
  "effectiveFrom" : "2012-01-11",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "M07.0"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "6(a)",
    "text" : "having psoriasis at the time of the clinical onset of psoriatic\r\narthropathy",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(b)",
    "text" : "having a discrete injury to the affected joint, sufficient to warrant\r\nmedical consultation, in the one month before the clinical onset of\r\npsoriatic arthropathy",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(c)",
    "text" : "being treated with efalizumab at the time of clinical onset of psoriatic\r\narthropathy",
    "definedTerms" : [ ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "6(d)",
    "text" : "inability to obtain appropriate clinical management for psoriatic\r\narthropathy",
    "definedTerms" : [ ]
  } ]
}